KHATAB ET AL.
3 of 8
analysis: calcd. For C H O , C, 68.42; H, 3.53. Found: C,
32.88, 50.24, 111.47, 125.46, 127.56, 127.63, 147.15,
149.32, 194.36. Anal. Calcd for C H O : C, 78.83; H,
26
16 8
6
8.56; H, 3.71.
23
26 3
7.48; O, 13.70; Found: C, 78.92; H, 7.59.
3
,3′‐(3‐chloro‐3‐(4‐chlorophenyl)prop‐2‐ene‐1,1‐diyl)
bis(4‐hydroxy‐2H‐chromen‐2‐one) (3j)
Mp. = 234 °C; IR (cm , KBr): 2934, 1711, 1627; H NMR
1,4‐bis(3,3,6,6‐Tetramethyl‐1,8‐dioxo‐2,3,4,5,6,7‐
hexahydroxanthene‐9‐yl)benzene. (7j)
−
1
1
−
1
(
CDCl ; 400 MHz): δ 3.5(brs,1H, OH), 5.1(d,1H, CH), 6.01
M.p. >300 °C; IR (KBr, cm ) ν max = 2957, 2872, 1667,
3
−
1 1
(d, 1H, =CH), 7.37 (t, 2H, ArH), 7.46–7.53 (m, 4H, Ar ‐H),
1624 cm ; H NMR (400 MHz, CDC1 ): δ = 0.99 (s, 12H,
3
7
.62(t, 1H, ArH), 7.7 2(t, 1H, ArH), 7.88(d, 2H, ArH),
4 CH ), 1.09 (s, 12H, 4 CH ), 2.20 (s, 8H, 4CH ), 2.39 (dd,
3
3
2
8
.00(d, 1H, ArH), 8.13(d, 1H, ArH), 11,92 (brs, 1H, OH);
8H, 4CH ), 4.73 (s, 2H, CH), 7.10 (s, 4H, ArH). Anal.
2
1
3
C NMR (CDCl , 75 MHz): δ 160.9, 156.2,152.68,
calcd. For C H O : C, 77.14; H, 7.44. Found: C, 77.28;
3
40 46 6
1
1
52.45, 146.46 134, 132.92, 132.69, 131.47, 129.18,
26.55, 125.09,124.37, 123.2, 116.7, 114.3 and 101.5; anal-
H, 7.26.
ysis: calcd. For: C H16C O , C, 63.92; H, 3.18; Cl, 13.98;
27
l2 6
O, 18.92. Found: C, 63.5 2; H, 3.0 8; Cl, 13.5 8.
3
| RESULTS AND DISCUSSION
.1 | XRD experimental data
4
‐(bis(4‐hydroxy‐2‐oxo‐2H‐chromen‐3‐yl)methyl)
benzaldehyde (3 k)
3
−
1
Mp. = 175 °C; IR (cm , KBr): 3021, 2934, 2605,1667, 1611;
1
H NMR (CDCl ; 400 MHz): δ 6.04 (s, 1H, CH), 7.41 (m,
XRD pattern of both perovskite material and sample that
3
6
1
1
1
3
H, ArH), 7.6–6.85 (m, 6H, Ar ‐H), 9.91(s, 1H, CHO),
loaded with 10% V O5 were shown in (Figure 1).
2
13
2,92 (brs, 2H, 2OH); C NMR (CDCl , 75 MHz): δ
Obtained data was compared to that observed by different
authors and with that obtained from Joint Committee on
Powder Diffraction Standards (JCPDS) (JCPDS no. 84–
3
90.8, 162.8, 161.9, 150.2, 133.8, 128.3, 125.4, 123.2, 116.4,
04.3 and 36.2; analysis: calcd. For: C H O ,C,70.91; H,
26
16 7
.66; O, 25.43. Found: C, 70.56; H, 3.42.
0444) for cubic strontium titanate SrTiO and (JCPDS
3
no. 72–2041) tetragonal Sr TiO .
2
4
3
, 3′,3″,3″‐ (1,4‐phenylenebis (methanetriyl))tetrakis(4‐
Obtained data reveals the presence of crystalline sin-
hydroxy‐2H‐chromen‐2‐one (3 l)
gle phase of SrTiO with a sharp diffraction peaks at
25.75, 32.5, 39.94, 46.5, 57.7 and 67.8 attributed to (100),
(110), (111), (200), (211) and (220) diffraction planes of
3
−
1
1
Mp. = 272 °C; IR (cm , KBr): 3021, 2930, 1655, 1617; H
NMR (CDCl ; 400 MHz): δ 6.04 (s, 1H, CH), 7.11 (d, 4H,
3
13
ArH), 7.6–6.85 (m,16H, Ar ‐H), 11,92 (brs, 2H, 2OH);
C
cubic strontium titanate phase (SrTiO ) (JCPDS card no.
3
NMR (CDCl , 75 MHz): δ 162.82, 161.9 152.2, 141.8,
84–0444).
3
1
28.3, 125.8, 123.2, 116.7, 107.3 and 36.8; analysis: calcd.
The crystallite size of synthesized catalyst was calcu-
lated by X‐ray line broadening route according to the
well‐known Scherrer formula:
For: C H O ,C,70.78; H, 3.51; O, 25.71. Found: C,
44
26 12
7
8.56; H, 3.31.
1
,4‐bis (di(1H‐indol‐3‐yl)methyl) benzene (5j)
1
Mp.183–184 °C; H NMR (400 MHz, CDCl ) 7.38–7.35 (m,
3
8
H, ArH), 7.25–7.21 (m, 8H, ArH), 7.14 (d, 4H, ArH), 7.01
13
(d, 4H, ArH), 6.25–6.23 (m, 4H, ArH), 5.75 (s, 2H).
C
NMR (75 MHz, CDCl ) 141.6, 136.7, 128.6, 127.1, 123.6,
3
1
21.8, 120.0, 119.7, 119.0, 111.1, 39.9. Anal. calcd for
C H N C, 84.78; H, 5.34; N, 9.89; found, C, 84.9 8; H,
40
30 4
5
.1 4; N, 9.6 9.
3
,4,6,7‐tetrahydro‐3,3,6,6‐tetramethyl‐9‐phenyl‐2H‐xan-
thene‐1,8(5H,9H)‐dione (7a)
M. P.: 203–204 °C; IR (KBr, Cm ) ν max = 2950, 1660,
−
1
1
1
(
2
(
648, 1360, 1200, 1162, 1141, 998, 694. H NMR
300 MHz, DMSO‐d6): δ: 0.90 (s, 6H), 1.04 (s, 6H), 2.07–
.10 (d, 2H), 2.25–2.28 (d, 2H), 2.51–2.60 (m, 3H), 4.53
s, 1H), 7.09–7.12 (t, 1H), 7.17–7.18 (d, 1H), 7.20–7.23 (t,
FIGURE 1 XRD pattern of both perovskite material and sample
that loaded with 10% V O
2 5
13
3
H). C NMR (DMSO, 75 MHz), δ: 26.45, 29.13, 32.14,